BLAINJECTIONINJECTABLE
Approved
Mar 1983
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 3h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MICROLITE is a technetium Tc-99m albumin colloid kit used as a diagnostic imaging agent for nuclear medicine procedures. It is a radiopharmaceutical preparation that localizes in the reticuloendothelial system and is used for imaging various organs and tissues. The colloid particles are taken up by macrophages, enabling visualization of organ function and detection of pathology.
LOE Approaching
As a legacy diagnostic radiopharmaceutical approaching loss of exclusivity, this product likely operates with a lean, mature commercial team focused on retention rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter
Started Oct 2005
11 enrolled
Liver Cancer
Career Relevance
Working on MICROLITE offers limited growth opportunities given its legacy status and approaching loss of exclusivity, but provides stable, specialized experience in radiopharmaceutical development, regulatory maintenance, and diagnostic imaging markets. Career progression typically involves transitioning to newer pipeline products or specializing in radiopharmaceutical operations and compliance.
Regulatory Affairs Specialist
Worked on MICROLITE at PharmaLundensis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.